Anti cancer effects of curcumin: Cycle of life and death

Cell Division

Volumn 3, Issue , 2008, Pages

  Sa, Gaurisankar ^a   Das, Tanya ^a  

^a BOSE INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 54949150290     PISSN: None     EISSN: 17471028     Source Type: Journal    
DOI: 10.1186/1747-1028-3-14     Document Type: Review

References (101)

1. McMichael AJ McCall MG Hartchorne JM Woodings TL Patterns of gastrointestinal cancer in European migrants to Australia: The role of dietary change Int J Cancer 1980, 5:431-437. 10.1002/ijc.2910250402
2. Wargovich MJ Nutrition and cancer: The herbal revolution Curr Opin Clin Nutr Metab Care 1999, 2:421-424. 10.1097/00075197-199909000-00011 10589385
3. Campbell FC Collett PG Chemopreventive properties of curcumin Future Oncol 2005, 1:405-414. 10.1517/14796694.1.3.405 16556014
4. Sharma RA Gescher AJ Steward WP Curcumin: The story so far Eur J Cancer 2005, 41:1955-1968. 10.1016/j.ejca.2005.05.009 16081279
5. Sharma OP Antioxidant activity of curcumin and related compounds Biochem Pharmacol 1976, 25:1811-1812. 10.1016/0006-2952(76)90421-4 942483
6. Choudhuri T Pal S Das T Sa G Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner J Biol Chem 2005, 280:20059-20068. 10.1074/ jbc.M410670200 15738001
7. Bhattacharyya S Mandal D Sen GS Pal S Banerjee S Lahiry L Finke JH Tannenbaum CS Das T Sa G Tumor-induced oxidative stress perturbs NFκB activity augmenting TNFα-mediated T cell death: Protection by curcumin Cancer Res 2007, 60:362-370. 10.1158/ 0008-5472.CAN-06-2583
8. Lowe SW Cepero E Evan G Intrinsic tumor suppression Nature 2004, 432:307-315. 10.1038/nature03098 15549092
9. Evan GI Vousden KH Proliferation, cell cycle and apoptosis in cancer Nature 2001, 411:342-348. 10.1038/35077213 11357141
10. Sherr CJ Cancer cell cycles Science 1996, 274:1672-1677. 10.1126/ science.274.5293.1672 8939849
11. Danial NN Korsmeyer SJ Cell death: Critical control points Cell 2004, 116:205-219. 10.1016/S0092-8674(04)00046-7 14744432
12. Hahn WC Weinberg RA Rules for making human tumor cells N Engl J Med 2002, 347:1593-1603. 10.1056/NEJMra021902 12432047
13. Norbury C Nurse P Animal cell cycles and their control Annu Rev Biochem 1992, 61:441-470. 10.1146/annurev.bi.61.070192.002301 1497317
14. Nurse P Masui Y Hartwell L Understanding the cell cycle Nat Med 1998, 4:1103-1106. 10.1038/2594 9771732
15. Hartwell LH Kastan MB Cell cycle control and cancer Science 1994, 266:1821-1828. 10.1126/science.7997877 7997877
16. Diehl JA Cycling to cancer with cyclin D1 Cancer Biol Thera 2002, 1:226-231.
17. Yu Q Geng Y Sicinski P Specific protection against breast cancers by cyclin D1 ablation Nature 2001, 411:1017-1021. 10.1038/35082500 11429595
18. Weinstein IB Relevance of cyclin D1 and other molecular markers to cancer chemoprevention J Cell Biochem Suppl 1996, 25:23-28. 10.1002/ (SICI)1097-4644(1996)25+<23::AID-JCB3>3.0.CO;2-4 9027594
19. Hosokawa Y Arnold A Mechanism of cyclin D1 (CCND1, PRAD1) over-expression in human cancer cells: Analysis of allele-specific expression Genes Chromosomes Cancer 1998, 22:66-71. 10.1002/ (SICI)1098-2264(199805)22:1<66::AID-GCC9>3.0.CO;2-5 9591636
20. Hinds PW Dowdy SF Eaton EN Arnold A Weinberg RA Function of a human cyclin gene as an oncogene Proc Natl Acad Sci, USA 1994, 91:709-713. 10.1073/pnas.91.2.709
21. AI Robles ML Rodriguez-Puebla AB Glick C Trempus L Hansen P Sicinski RW Tennant RA Weinberg SH Yuspa CJ Conti Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo Genes Dev 1998, 12:2469-2474. 317082 9716400 10.1101/gad.12.16.2469
22. Wang TC Cardiff RD Zukerberg L Lees E Arnold A Schmidt EV Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice Nature 1994, 369:669-671. 10.1038/369669a0 8208295
23. Bortner DM Rosenberg MP Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E Mol Cell Biol 1997, 17:453-459. 231770 8972226
24. Harbour JW Dean DC Rb function in cell cycle regulation and apoptosis Nat Cell Biol 2000, 2:65-67. 10.1038/35008695
25. Sherr CJ Roberts JM CDK inhibitors: Positive and negative regulators of G1-phase progression Genes Dev 1999, 13:1501-1512. 10.1101/ gad.13.12.1501 10385618
26. Sa G Stacey DW P27 expression is regulated by separate signaling pathways, downstream of Ras, in each cell cycle phase Exp Cell Res 2004, 300:427-439. 10.1016/j.yexcr.2004.07.032 15475007
27. Ortega S Malumbres M Barbacid M Cyclin D-dependent kinases, INK4 inhibitors and cancer Biochim Biophys Acta 2002, 1602:73-87. 11960696
28. Vidal A Koff A Cell-cycle inhibitors: Three families united by a common cause Gene 2000, 247:1-15. 10.1016/S0378-1119(00)00092-5 10773440
29. Elledge SJ Cell cycle checkpoints: Preventing an identity crisis Science 1996, 274:1664-1672. 10.1126/science.274.5293.1664 8939848
30. Hollstein M Sidransky D Vogelstein B Harris CC p53 mutations in human cancers Science 1991, 253:49-53. 10.1126/science.1905840 1905840
31. Polyak K Waldman T He T-C Kinzler KW Vogelstein B Genetic determinants of p53-induced apoptosis and growth arrest Genes Dev 1996, 10:1945-1952. 10.1101/gad.10.15.1945 8756351
32. Levin AJ p53, the cellular gatekeeper for growth and division Cell 1997, 88:323-331. 10.1016/S0092-8674(00)81871-1 9039259
33. Grimmler M Wang Y Mund T Cilensek Z Keidel EM Waddell MB Jäkel H Kullmann M Kriwacki RW Hengst L Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases Cell 2007, 128:269-80. 10.1016/j.cell.2006.11.047 17254966
34. Chu I Sun J Arnaout A Kahn H Hanna W Narod S Sun P Tan CK Hengst L Slingerland J p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2 Cell 2007, 128:281-94. 1961623 17254967 10.1016/j.cell.2006.11.049
35. Miyashita T Reed JC Tumor suppressor p53 is a direct transcriptional activator of the human bax gene Cell 1995, 80:293-299. 10.1016/ 0092-8674(95)90513-8 7834749
36. Das T Sa G Sinha P Ray PK Induction of cell proliferation and apoptosis: dependence on the dose of the inducer Biochem Biophys Res Commun 1999, 260:105-110. 10.1006/bbrc.1999.0712 10381351
37. Harrington EA Fanidi A Evan GI Oncogenes and cell death Curr Opinion Genet Dev 1994, 4:120-129. 10.1016/0959-437X(94)90100-7
38. Liu X Kim CN Yang J Jemmerson R Wang X Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c Cell 1996, 86:147-157. 10.1016/S0092-8674(00)80085-9 8689682
39. Waldman T Yongyang Y Diollehay L Yu J Kinzler KW Vogelstein B Williams J Cell cycle arrest versus cell death in cancer therapy Nat Med 1997, 3:1034-1036. 10.1038/nm0997-1034 9288734
40. Strimpakos AS Sharma RA Curcumin: Preventive and therapeutic properties in laboratory studies and clinical trials Antioxid Redox Signal 2008, 10:511-45. 10.1089/ars.2007.1769 18370854
41. Oyama Y Masuda T Nakata M Chikahisa L Yamazaki Y Miura K Okagawa M Protective actions of 5'-n-alkylated curcumins on living cells suffering from oxidative stress Eur J Pharmacol 1998, 360:65-71. 10.1016/ S0014-2999(98)00635-9 9845274
42. Pal S Bhattacharya S Choudhuri T Datta GK Das T Sa G Amelioration of immune cell number depletion and potentiation of depressed detoxification system of tumor-bearing mice by curcumin Cancer Detection Prevention 2005, 29:470-478. 10.1016/j.cdp.2005.05.003
43. Sugimoto K Hanai H Tozawa K Aoshi T Uchijima M Nagata T Koide Y Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice Gastroenterology 2002, 123:1912-1922. 10.1053/gast.2002.37050 12454848
44. Pal S Choudhuri T Chattopadhyay S Bhattacharya A Datta G Das T Sa G Mechanisms of curcumin-induced apoptosis of Ehrlich's ascites carcinoma cells Biochem Biophys Res Commun 2001, 288:658-665. 10.1006/ bbrc.2001.5823 11676493
45. Ammon HP Wahl MA Pharmacology of Curcuma longa Planta Med 1991, 57:1-7. 10.1055/s-2006-960004 2062949
46. Vial T Descotes J Immunosuppressive drugs and cancer Toxicology 2003, 185:229-240. 10.1016/S0300-483X(02)00612-1 12581698
47. Choudhuri T Pal S Agwarwal ML Das T Sa G Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction FEBS Lett 2002, 512:334-340. 10.1016/S0014-5793(02)02292-5 11852106
48. Dhillon N Aggarwal BB Newman RA Wolff RA Kunnumakkara AB Abbruzzese JL Ng CS Badmaev V Kurzrock R Phase II trial of curcumin in patients with advanced pancreatic cancer Clin Cancer Res 2008, 14:4491-4499. 10.1158/ 1078-0432.CCR-08-0024 18628464
49. Aggarwal BB Kumar A Bharti AC Anticancer potential of curcumin: preclinical and clinical studies Anticancer Res 2003, 23:363-398. 12680238
50. Cheng AL Hsu CH Lin JK Hsu MM Ho YF Shen TS Ko JY Lin JT Lin BR Ming-Shiang W Yu HS Jee SH Chen GS Chen TM Chen CA Lai MK Pu YS Pan MH Wang YJ Tsai CC Hsieh CY Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions Anticancer Res 2001, 21:2895-2900. 11712783
51. Kuttan R Sudheeran PC Josph CD Turmeric and curcumin as topical agents in cancer therapy Tumori 1987, 73:29-31. 2435036
52. Garcea G Berry DP Jones DJ Singh R Dennison AR Farmer PB Sharma RA Steward WP Gescher AJ Consumption of the putative chemopreventive agent curcumin by cancer patients: Assessment of curcumin levels in the colorectum and their pharmacodynamic consequences Cancer Epidemiol Biomarkers Prev 2005, 14:120-125. 15668484
53. Ireson C Orr S Jones DJ Verschoyle R Lim CK Luo JL Howells L Plummer S Jukes R Williams M Steward WP Gescher A Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production Cancer Res 2001, 61:1058-1064. 11221833
54. Huang MT Wang ZY Georgiadis CA Laskin JD Conney AH Inhibitory effects of curcumin on tumor initiation by benzo[α]pyrene and 7,12-dimethylbenz[α]anthracene Carcinogenesis 1992, 13:2183-2186. 10.1093/carcin/13.11.2183 1423891
55. Huang MT Newmark HL Frenkel KJ Inhibitory effects of curcumin on tumorigenesis in mice Biochem Suppl 1997, 27:326-34.
56. Jee SH Shen SC Tseng CR Chiu HC Kuo ML Curcumin induces a p53-dependent apoptosis in human basal cell carcinoma cells J Invest Dermatol 1998, 111:656-661. 10.1046/j.1523-1747.1998.00352.x 9764849
57. Moos PJ Edes K Mullally JE Fitzpatrick FA Curcumin impairs tumor suppressor p53 function in colon cancer cells Carcinogenesis 2004, 25:1611-1617. 10.1093/carcin/bgh163 15090465
58. Park C Kim GY Kim GD Choi BT Park YM Choi YH Induction of G2/M arrest and inhibition of cyclooxygenase-2 activity by curcumin in human bladder cancer T24 cells Oncol Rep 2006, 15:1225-1231. 16596191
59. Liontas A Yeger H Curcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastoma Anticancer Res 2004, 24:987-998. 15161054
60. Pillai GR Srivastava AS Hassanein TI Chauhan DP Carrier E Induction of apoptosis in human lung cancer cells by curcumin Cancer Lett 2004, 208:163-170. 10.1016/j.canlet.2004.01.008 15142674
61. Shi M Cai Q Yao L Mao Y Ming Y Ouyang G Antiproliferation and apoptosis induced by curcumin in human ovarian cancer cells Cell Biol Int 2006, 30:221-226. 10.1016/j.cellbi.2005.10.024 16376585
62. Jaiswal AS Marlow BP Gupta N Narayan S Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells Oncogene 2002, 21:8414-8427. 10.1038/sj.onc.1205947 12466962
63. Bharti AC Donato N Singh S Aggarwal BB Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis Blood 2003, 101:1053-1062. 10.1182/blood-2002-05-1320 12393461
64. Chen A Xu J Activation of PPAR{gamma} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR Am J Physiol Gastrointest Liver Physiol 2005, 288:G447-456. 10.1152/ ajpgi.00209.2004 15486348
65. Leu TH Su SL Chuang YC Maa MC Direct inhibitory effect of curcumin on Src and focal adhesion kinase activity Biochem Pharmacol 2003, 66:2323-2331. 10.1016/j.bcp.2003.08.017 14637190
66. Nakamura K Yasunaga Y Segawa T Ko D Moul JW Srivastava S Rhim JS Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines Int J Oncol 2002, 21:825-830. 12239622
67. Balasubramanyam K Varier RA Altaf M Swaminathan V Siddappa NB Ranga U Kundu TK Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription J Biol Chem 2004, 279:51163-51171. 10.1074/jbc.M409024200 15383533
68. Collett GP Campbell FC Curcumin induces c-jun N-terminal kinase-dependent apoptosis in HCT116 human colon cancer cells Carcinogenesis 2004, 25:2183-2189. 10.1093/carcin/bgh233 15256484
69. Deeb D Xu YX Jiang H Gao X Janakiraman N Chapman RA Gautam SC Curcumin (Diferuloyl-Methane) enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in LNCaP prostate cancer cells Mol Cancer Ther 2003, 2:95-103. 12533677
70. Dorai T Gehani N Katz A Therapeutic potential of curcumin in human prostate cancer-I. Curcumin induces apoptosis in both androgen-dependent and androgen-independent prostate cancer cells Prostate Cancer Prostatic Dis 2000, 3:84-93. 10.1038/sj.pcan.4500399 12497104
71. Ramachandran C Fonseca HB Jhabvala P Escalon EA Melnick SJ Curcumin inhibits telomerase activity through human telomerase reverse transcritpase in MCF-7 breast cancer cell line Cancer Lett 2002, 184:1-6. 10.1016/S0304-3835(02)00192-1 12104041
72. Wolanin K Magalska A Mosieniak G Klinger R McKenna S Vejda S Sikora E Piwocka K Curcumin affects components of the chromosomal passenger complex and induces mitotic catastrophe in apoptosis-resistant Bcr-Abl-expressing cells Mol Cancer Res 2006, 4:457-469. 10.1158/ 1541-7786.MCR-05-0172 16849521
73. Zheng M Ekmekcioglu S Walch ET Tang CH Grimm EA Inhibition of nuclear factor-kappaB and nitric oxide by curcumin induces G2/M cell cycle arrest and apoptosis in human melanoma cells Melanoma Res 2004, 14:165-171. 10.1097/01.cmr.0000129374.76399.19 15179184
74. Shishodia S Amin HM Lai R Aggarwal BB Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma Biochem Pharmacol 2005, 70:700-701. 10.1016/j.bcp.2005.04.043 16023083
75. Rajasingh J Raikwar HP Muthia G Johnson C Bright JJ Curcumin induces growth-arrest and apoptosis in association with the inhibition of constitutively active JAK-STAT pathway in T cell leukemia Biochem Biophys Res Commun 2006, 340:359-368. 10.1016/j.bbrc.2005.12.014 16364242
76. Tomita M Kawakami H Uchihara JN Curcumin (diferuloylmethane) inhibits constitutive active NF-kappaB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells Int J Cancer 2006, 118:765-772. 10.1002/ ijc.21389 16106398
77. Holy JM Curcumin disrupts mitotic spindle structure and induces micronucleation in MCF-7breast cancer cells Mutat Res 2002, 518:71-84. 12063069
78. Woo JH Kim YH Choi YJ Kim DG Lee KS Bae JH Min DS Chang JS Jeong YJ Lee YH Park JW Kwon TK Molecular mechanisms of curcumin-induced cytotoxicity: Induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt Carcinogenesis 2003, 24:1199-1208. 10.1093/carcin/bgg082 12807727
79. Sa G Hitomi M Harwalkar J Stacey A Chen G Stacey DW Ras is active throughout the cell cycle, but is able to induce cyclin D1 only during G2 phase Cell Cycle 2002, 1:50-58. 12429909
80. Sa G Guo Y Stacey DW Regulation of S phase initiation by p27Kip1 in NIH3T3 cells Cell Cycle 2005, 4:618-627. 15876875
81. Hitomi M Stacey DW Cellular ras and cyclin D1 are required during different cell cycle periods in cycling NIH 3T3 cells Mol Cell Biol 1999, 19:4623-4632. 84260 10373511
82. Mukhopadhyay A Banerjee S Stafford LJ Xia CX Liu M Aggarwal BB Curcumin induced suppression of cell proliferation correlates with downregulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation Oncogene 2002, 21:8852-8862. 10.1038/sj.onc.1206048 12483537
83. Park MJ Kim EH Park IC Lee HC Woo SH Lee JY Hong YJ Rhee CH Choi SH Shim BS Lee SH Hong SI Curcumin inhibits cell cycle progression of immortalized human umbilical vein endothelial (ECV304) cells by up-regulating cyclin-dependent kinase inhibitor, p21WAF1/CIP1, p27KIP1 and p53 Int J Oncol 2002, 21:379-383. 12118335
84. Bech-Otschir D Kraft R Huang X COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system EMBO J 2001, 20:1630-1639. 145508 11285227 10.1093/emboj/20.7.1630
85. Song G Mao YB Cai QF Yao LM Ouyang GL Bao SD Curcumin induces human HT-29 colon adenocarcinoma cell apoptosis by activating p53 and regulating apoptosis-related protein expression Braz J Med Biol Res 2005, 38:1791-1798. 10.1590/S0100-879X2005001200007 16302093
86. Kamath R Jiang Z Sun G Yalowich JC Rajasekaran B c-Abl kinase regulates curcumin-induced cell death through activation of c-Jun N-terminal kinase Mol Pharmacol 2007, 71:61-72. 10.1124/mol.106.026575 17021249
87. Bush JA Cheung KJ Jr Li G Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53 Exp Cell Res 2001, 271:305-314. 10.1006/excr.2001.5381 11716543
88. Mullally JE Fitzpatrick FA Pharmacophore model for novel inhibitors of ubiquitin isopeptidases that induce p53-independent cell death Mol Pharmacol 2002, 69:351-358. 10.1124/mol.62.2.351
89. Chen J Huang CY Guan JY Lu SH Pu YS Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21WAF1/ CIP1 and C/EBPβ expressions and suppressing NF-κB activation hour The prostate 2002, 51:211-218. 10.1002/pros.10089 11967955
90. Lin JK Suppression of protein kinase C and nuclear oncogene expression as possible action mechanisms of cancer chemoprevention by curcumin Arch Pharm Res 2004, 27:683-692. 15356994
91. Choi H Chun YS Kim SW Kim MS Park JW Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: A mechanism of tumor growth inhibition Mol Pharmaco 2006, 70:1664-1671. 10.1124/mol.106.025817
92. Mohan R Sivak J Ashton P Russo LA Pham BQ Kasahara N Raizman MB Fini ME Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B J Biol Chem 2000, 275:10405-10412. 10.1074/jbc.275.14.10405 10744729
93. Lala PK Chakraborty C Role of nitric oxide in carcinogenesis and tumour progression Lancet Oncol 2001, 2:149-56. 10.1016/S1470-2045(00)00256-4 11902565
94. Bae MK Kim SH Jeong JW Lee YM Kim HS Kim SR Yun I Bae SK Kim KW Curcumin inhibits hypoxia-induced angiogenesis via down-regulation of HIF-1 Oncol Rep 2006, 15:1557-1562. 16685395
95. Park CH Hahm ER Park S Kim HK Yang CH The inhibitory mechanism of curcumin and its derivative against beta-catenin/Tcf signaling FEBS Lett 2005, 579:2965-2971. 10.1016/j.febslet.2005.04.013 15893313
96. Khopde M Priyadarsini KI Venkatesan P Rao MN Free radical scavenging ability and antioxidant efficiency of curcumin and its substituted analogue Biophys Chem 1999, 80:85-91. 10.1016/S0301-4622(99)00070-8 17030320
97. Graziewicz M Wink DA Laval F Nitric oxide inhibits DNA ligase activity: potential mechanisms for NO-mediated DNA damage Carcinogenesis 1996, 17:2501-2505. 10.1093/carcin/17.11.2501 8968069
98. Mori Y Tatematsu K Koide A Sugie S Tanaka T Mori H Modification by curcumin of mutagenic activation of carcinogenic N-nitrosamines by extrahepatic cytochromes P-450 2B1 and 2E1 in rats Cancer Sci 2006, 97:896-904. 10.1111/j.1349-7006.2006.00261.x 16805852
99. Jagetia GC Aggarwal BB "Spicing up" of the immune system by curcumin J Clin Immunol 2007, 27:19-35. 10.1007/s10875-006-9066-7 17211725
100. Bhaumik S Jyothi MD Khar A Differential modulation of nitric oxide production by curcumin in host macrophages and NK cells FEBS Lett 2000, 483:78-82. 10.1016/S0014-5793(00)02089-5 11033360
101. Bhattacharyya S Mandal D Saha B Sen GS Das T Sa G Curcumin prevents tumor-induced T cell apoptosis through Stat-5a-mediated Bcl-2 induction J Biol Chem 2007, 282:15954-15964. 10.1074/jbc.M608189200 17392282